Regulations in various countries permit the reuse of health information without patient authorization provided the data is "de-identified". In the United States, for instance, the Privacy Rule of the Health Insurance Portability and Accountability Act defines two distinct approaches to achieve de-identification; the first is , which requires the removal of a list of identifiers and the second is , which requires that an expert certify the re-identification risk inherent in the data is sufficiently low. In reality, most healthcare organizations eschew the expert route because there are no standardized approaches and Safe Harbor is much simpler to interpret. This, however, precludes a wide range of worthwhile endeavors that are dependent on features suppressed by Safe Harbor, such as gerontological studies requiring detailed ages over 89. In response, we propose a novel approach to automatically discover alternative de-identification policies that contain no more re-identification risk than Safe Harbor. We model this task as a lattice-search problem, introduce a measure to capture the re-identification risk, and develop an algorithm that efficiently discovers polices by exploring the lattice. Using a cohort of approximately 3000 patient records from the Vanderbilt University Medical Center, as well as the Adult dataset from the UCI Machine Learning Repository, we also experimentally verify that a large number of alternative policies can be discovered in an efficient manner.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267471PMC
http://dx.doi.org/10.1145/1882992.1883017DOI Listing

Publication Analysis

Top Keywords

safe harbor
16
re-identification risk
12
safe
4
harbor automatic
4
automatic discovery
4
discovery health
4
health de-identification
4
de-identification policy
4
policy alternatives
4
alternatives regulations
4

Similar Publications

Navigating Limited Resources-Outpatient Pediatric Cholecystectomies at Rural Hospitals.

J Pediatr Surg

January 2025

Department of Surgery, Harbor-UCLA Medical Center, 1000 W. Carson Street, Box 42, Torrance, CA 90502, USA; Division of Pediatric Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, 77-123 CHS, Los Angeles, CA 90095, USA. Electronic address:

Background: Rural facilities that provide pediatric surgical services are a critical resource to local communities. Our aim was to characterize differences in outpatient pediatric cholecystectomy outcomes performed at rural and urban hospitals with the hypothesis that rural hospitals would have similar outcomes.

Methods: The Nationwide Ambulatory Surgery Sample (NASS), which contains ambulatory surgery encounters at hospital-owned facilities, was used to perform a retrospective cohort analysis of pediatric patients age 18-years and younger who had a cholecystectomy (n = 15,449) between 2016 and 2018.

View Article and Find Full Text PDF

Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK TKIs) show robust efficacy and has revolutionized the treatment of NSCLC patients harboring an ALK-rearrangement. Side effects, sometimes even serious such as pneumonitis, can occur with ALK TKIs. We report a case of a patient with ALK positive advanced NSCLC who developed pneumonitis during treatment with first-line alectinib.

View Article and Find Full Text PDF

An obscure gene editor was used to restore a missing liver enzyme in an infant with a devastating metabolic condition.

View Article and Find Full Text PDF

Antibiotic resistance genes (ARGs) rebounding during composting cooling phase is a critical bottleneck in composting technology that increased ARGs dissemination and application risk of compost products. In this study, mature compost (MR) was used as a substitute for rice husk (RH) to mitigate the rebound of ARGs and mobile genetic elements (MGEs) during the cooling phase of sewage sludge composting, and the relationship among ARGs, MGEs, bacterial community and environmental factors was investigated to explore the key factor influencing ARGs rebound. The results showed that aadD, blaCTX-M02, ermF, ermB, tetX and vanHB significantly increased 4.

View Article and Find Full Text PDF

Oncolytic viruses expressing MATEs facilitate target-independent T-cell activation in tumors.

EMBO Mol Med

January 2025

Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.

Oncolytic viruses (OV) expressing bispecific T-cell engagers (BiTEs) are promising tools for tumor immunotherapy but the range of target tumors is limited. To facilitate effective T-cell stimulation with broad-range applicability, we established membrane-associated T-cell engagers (MATEs) harboring the protein transduction domain of the HIV-Tat protein to achieve non-selective binding to target cells. In vitro, MATEs effectively activated murine T cells and improved killing of MC38 colon carcinoma cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!